Processa Pharmaceuticals ...

NASDAQ: PCSA · Real-Time Price · USD
0.24
-0.00 (-1.40%)
At close: May 23, 2025, 2:28 PM
-1.40%
Bid 0.24
Market Cap 2.88M
Revenue (ttm) n/a
Net Income (ttm) -11.96M
EPS (ttm) -3.06
PE Ratio (ttm) -0.08
Forward PE -0.28
Analyst Buy
Ask 0.24
Volume 8,478,816
Avg. Volume (20D) 2,566,490
Open 0.25
Previous Close 0.24
Day's Range 0.23 - 0.32
52-Week Range 0.15 - 3.10
Beta 1.35

About PCSA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PCSA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PCSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
-3.7%
Processa Pharmaceuticals shares are trading lower ... Unlock content with Pro Subscription
7 months ago
+0%
Processa Pharmaceuticals shares are trading higher after the company announced the dosing of its first patient for the Phase 2 trial of NGC-Cap.